It takes about 15 minutes research to see that this is a massively undervalued company if they can get access to their leases, so it's worth holding beyond one bad day on the market.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025